General-purpose generative AI for research, education, administration and clinical support tasks. Versa Chat offers a web chat interface; Versa API supports automation and large datasets. Not a clinical decision tool.
Regulatory status
Internal platform operated by UCSF IT. UCSF states that data stays within UCSF and that the platform is HIPAA-compliant (not independently verified). Not a medical device.
Clinical evidence
Vendor-supported
Independent
Real-world deployment
Launched in August 2023 and available to UCSF faculty, staff and learners after a short training.
Interoperability
European status
Editorial verdict
Limits and uncertainties
– Platform built on commercial large language models (GPT-3.5 and GPT-4 at launch): in-house governance, not an in-house model.
– No published outcome or quality data identified.
– General-purpose tool: clinical use cases need their own validation and oversight.
Sources
News, UCSF IT, Versa generative AI platform now available:
https://it.ucsf.edu/news/ucsfs-versa-generative-ai-platform-now-available
This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate
At a glance
Vendor
University of California, San Francisco (UCSF)
Headquarters
USA
AI type
RAG / Knowledge AI
Specialty
Clinical role
Adjunct (decision support)
CE marking
Notified body
EU AI Act
Data hosting
Last verified
Reviewed by
How we evaluate
Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.
A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.